๐Ÿ•ต๏ธ 89BIO, Inc. ($ETNB)

SEC insider & ownership activity, last 12 months ยท CIK 1785173 ยท every row links its SEC filing

Insiders were quiet over the last 12 months โ€“ no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Oct 30, 2025.

Insider flow

0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

HolderStakeClassScheduleEvent
Aaron Cowen 8.5% 13GFeb 13, 2025 filing โ†—
Averill Master Fund, Ltd. 7.7% 13GFeb 13, 2025 filing โ†—
The Vanguard Group 5.6% 13GJul 29, 2025 filing โ†—
Suvretta Capital Management, LLC 5.6% 13GNov 13, 2025 filing โ†—
Aaron Cowen 5.6% 13GNov 13, 2025 filing โ†—
DEEP Track Capital, LP 5.4% 13GDec 23, 2024 filing โ†—
DEEP Track Biotechnology Master Fund, Ltd. 5.4% 13GDec 23, 2024 filing โ†—
David Kroin 5.4% 13GDec 23, 2024 filing โ†—
Janus Henderson Biotech Innovation Master Fund Ltd 5.1% 13GAug 14, 2025 filing โ†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Agreement terminated (1.02)Oct 30, 2025 filing โ†—
Acquisition or disposition (2.01)Oct 30, 2025 filing โ†—
Delisting notice (3.01)Oct 30, 2025 filing โ†—
Material Modifications to Rights of Security Holders (3.03)Oct 30, 2025 filing โ†—
Change of control (5.01)Oct 30, 2025 filing โ†—
Officer/director changes (5.02)Oct 30, 2025 filing โ†—
Charter/bylaw changes (5.03)Oct 30, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Oct 30, 2025 filing โ†—
Material agreement (1.01)Sep 17, 2025 filing โ†—
Other events (8.01)Sep 17, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Sep 17, 2025 filing โ†—
Earnings (2.02)Aug 7, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Aug 7, 2025 filing โ†—